2025 Family Conference: Primary Prevention Update

Description: An update on recent developments in the DIAN primary prevention studies, including progress on trial enrollments for upcoming studies on the effectiveness of potential anti-amyloid immunotherapy drugs
Runtime: 00:04:02

Speaker: Eric McDade, DO
Speaker title: DIAN Observational Study Director; DIAN Trials Unit Co-Director
Speaker organization: Washington University in St. Louis

Event: 2025 DIAD Family Conference: Dedicated to Impact
Location: Toronto, Ontario, Canada
Year: 2025

Search tags: primary prevention, amyloid plaques, tau tangles, remternetug, donanemab, anti-amyloid immunotherapy, research participation